Saturday 17 October 2026
Export SI’s income statement to Excel — free account
Shoulder Innovations, Inc.
Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024. In the quarter to June 2026, revenue grew 56.0%, EPS grew 99.7%, free cash flow fell 52.4% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
18.09
0.28
−1.52%
Follow SI
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | — | 10.92 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | — | 17.94 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | 61 | 75 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | — | 0.52 | 0.63 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | 32 | 47 | ||||
| Gross margin, % | — | — | — | — | — | — | — | — | 76.97 | 76.51 | |||||
| EBT | — | — | — | — | — | — | — | — | (16) | (40) | |||||
| EBT margin, % | — | — | — | — | — | — | — | — | (49.39) | (85.29) | |||||
| Net income | — | — | — | — | — | — | — | — | (16) | (40) | |||||
| Depreciation | — | — | — | — | — | — | — | — | 3 | 3 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | — | 490.28 | 5.46 | ||||
| Earnings | — | — | — | — | — | — | — | — | (242.04) | (4.65) | |||||
| Cash flow | — | — | — | — | — | — | — | — | (219.27) | (3.30) | |||||
| Capex | — | — | — | — | — | — | — | — | (62.25) | (0.85) | |||||
| Free cash flow | — | — | — | — | — | — | — | — | (281.52) | (4.15) | |||||
| Book value | — | — | — | — | — | — | — | — | 306.67 | 16.23 | |||||
| Shares, m | — | — | — | — | — | — | — | — | 0 | 9 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | — | — | 0.05 | 2.62 | |||||
| P/B | — | — | — | — | — | — | — | — | 0.00 | 0.88 | |||||
| EV/Sales | — | — | — | — | — | — | — | — | (0.63) | 0.31 | |||||
| EV/FCF | — | — | — | — | — | — | — | — | 0.98 | (0.41) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | — | (14) | (29) | ||||
| Capex | — | — | — | — | — | — | — | — | (4) | (7) | |||||
| Free cash flow | — | — | — | — | — | — | — | — | (18) | (36) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | — | 27 | 143 | ||||
| Total debt | — | — | — | — | — | — | — | — | 15 | 15 | |||||
| Net debt | — | — | — | — | — | — | — | — | 0 | (109) | |||||
| Shareholders’ equity | — | — | — | — | — | — | — | — | 20 | 141 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | — | 0.00 | (37.90) | ||||
| ROIC | — | — | — | — | — | — | — | — | (47.22) | (52.42) | |||||
| ROE | — | — | — | — | — | — | — | — | 0.00 | (93.80) | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Shoulder Innovations, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| BWAY Brainsway Ltd. Sponsored ADR | $475.8M | 24.8× | — (loss-making) | +35.43% (above 0%: growing) | +40.00% (above 0%: growing) | −51.68% (below 0%: shrinking) | 74.62% | 13.98% | Compare |
| CERS Cerus Corporation | $455.5M | — (loss-making) | — (loss-making) | +5.28% (above 0%: growing) | n/m | −20.90% (below 0%: shrinking) | 55.91% | (2.94%) | Compare |
| NPCE NeuroPace, Inc. | $438.7M | — (loss-making) | — (loss-making) | +17.05% (above 0%: growing) | n/m | −78.70% (below 0%: shrinking) | 82.83% | (22.53%) | Compare |
| SENS Senseonics Holdings, Inc. | $435.2M | — (loss-making) | — (loss-making) | +117.82% (above 0%: growing) | n/m | −223.24% (below 0%: shrinking) | 59.10% | (248.48%) | Compare |
| OFIX ORTHOFIX MEDICAL INC. | $390.6M | — (loss-making) | — (loss-making) | +3.85% (above 0%: growing) | n/m | −516.58% (below 0%: shrinking) | 70.97% | (3.86%) | Compare |
| SI Shoulder Innovations, Inc. | $382.4M | — (loss-making) | — (loss-making) | +55.95% (above 0%: growing) | n/m | −52.42% (below 0%: shrinking) | 78.26% | (58.43%) | |
| VMD Viemed Healthcare, Inc. | $371.4M | 24.9× | 21.9× | +23.85% (above 0%: growing) | −12.50% (below 0%: shrinking) | −18.15% (below 0%: shrinking) | 57.68% | 6.39% | Compare |
| CV CapsoVision, Inc. | $343.2M | 2.1× | — (loss-making) | +9.89% (above 0%: growing) | n/m | −84.44% (below 0%: shrinking) | 51.36% | (208.07%) | Compare |
| RCEL Avita Medical Inc. | $333.1M | — (loss-making) | — (loss-making) | +17.83% (above 0%: growing) | n/m | +66.52% (above 0%: growing) | 81.87% | (28.42%) | Compare |
| Median of peers | $412.9M | 24.8× | — | +17.44% | — | −65.19% | 65.04% | (13.19%) |
Shoulder Innovations, Inc. (SI) key facts
- Strength: Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024.
- Shoulder Innovations, Inc. (SI) is a Medical Devices company in the Healthcare sector, listed on the New York Stock Exchange.
- As of October 16, 2026, SI traded at $18.09, a market capitalization of $382.4 million.
- Return on equity was −93.8% and debt-to-equity 0.12.
- Its Altman Z-score is 2.53 (grey zone) for fiscal 2025.